{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:36:08Z","timestamp":1794522968452,"version":"4.9.1"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"publisher","award":["2024-YF05-02230-SN"],"award-info":[{"award-number":["2024-YF05-02230-SN"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","award":["2024\u2013803"],"award-info":[{"award-number":["2024\u2013803"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Health Commission of Sichuan Province Medical Science and Technology Program","award":["24QNMP038"],"award-info":[{"award-number":["24QNMP038"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-025-03599-1","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T04:29:21Z","timestamp":1739593761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Associations of the gut, cervical, and vaginal microbiota with cervical cancer: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Qin","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalan","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"3","key":"3599_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"9895","key":"3599_CR2","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","volume":"382","author":"EJ Crosbie","year":"2013","unstructured":"Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382(9895):889\u201399.","journal-title":"Lancet"},{"issue":"2","key":"3599_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrclinonc.2013.252","volume":"11","author":"CJ Meijer","year":"2014","unstructured":"Meijer CJ, Snijders PJ. Cervical cancer in 2013: screening comes of age and treatment progress continues. Nat Rev Clin Oncol. 2014;11(2):77\u20138.","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"3599_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nat Med. 2019;25(3):377\u201388.","journal-title":"Nat Med"},{"key":"3599_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40168-015-0094-5","volume":"3","author":"JR Marchesi","year":"2015","unstructured":"Marchesi JR, Ravel J. The vocabulary of microbiome research: a proposal. Microbiome. 2015;3:31.","journal-title":"Microbiome"},{"issue":"4","key":"3599_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41585-020-0286-z","volume":"17","author":"P Laniewski","year":"2020","unstructured":"Laniewski P, Ilhan ZE, Herbst-Kralovetz MM. The microbiome and gynaecological cancer development, prevention and therapy. Nat Rev Urol. 2020;17(4):232\u201350.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"3599_CR7","doi-asserted-by":"publisher","first-page":"4680","DOI":"10.1073\/pnas.1002611107","volume":"108","author":"J Ravel","year":"2011","unstructured":"Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108(1):4680\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"132","key":"3599_CR8","doi-asserted-by":"publisher","first-page":"132ra52","DOI":"10.1126\/scitranslmed.3003605","volume":"4","author":"P Gajer","year":"2012","unstructured":"Gajer P, Brotman RM, Bai G, Sakamoto J, Sch\u00fctte UM, Zhong X, et al. Temporal dynamics of the human vaginal microbiota. Sci Transl Med. 2012;4(132):132ra52.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3599_CR9","doi-asserted-by":"publisher","first-page":"7593","DOI":"10.1038\/s41598-018-25879-7","volume":"8","author":"P \u0141aniewski","year":"2018","unstructured":"\u0141aniewski P, Barnes D, Goulder A, Cui H, Roe DJ, Chase DM, et al. Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-hispanic and hispanic women. Sci Rep. 2018;8(1):7593.","journal-title":"Sci Rep"},{"key":"3599_CR10","doi-asserted-by":"publisher","first-page":"16865","DOI":"10.1038\/srep16865","volume":"5","author":"A Mitra","year":"2015","unstructured":"Mitra A, MacIntyre DA, Lee YS, Smith A, Marchesi JR, Lehne B, et al. Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity. Sci Rep. 2015;5:16865.","journal-title":"Sci Rep"},{"issue":"4","key":"3599_CR11","doi-asserted-by":"publisher","first-page":"e0153274","DOI":"10.1371\/journal.pone.0153274","volume":"11","author":"A Audirac-Chalifour","year":"2016","unstructured":"Audirac-Chalifour A, Torres-Poveda K, Bahena-Rom\u00e1n M, T\u00e9llez-Sosa J, Mart\u00ednez-Barnetche J, Cortina-Ceballos B, et al. Cervical Microbiome and Cytokine Profile at various stages of cervical Cancer: a pilot study. PLoS ONE. 2016;11(4):e0153274.","journal-title":"PLoS ONE"},{"issue":"8","key":"3599_CR12","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s13238-010-0093-z","volume":"1","author":"B Zhu","year":"2010","unstructured":"Zhu B, Wang X, Li L. Human gut microbiome: the second genome of human body. Protein Cell. 2010;1(8):718\u201325.","journal-title":"Protein Cell"},{"issue":"6536","key":"3599_CR13","doi-asserted-by":"publisher","first-page":"eabc4552","DOI":"10.1126\/science.abc4552","volume":"371","author":"GD Sepich-Poore","year":"2021","unstructured":"Sepich-Poore GD, Zitvogel L, Straussman R, Hasty J, Wargo JA, Knight R. The microbiome and human cancer. Science. 2021;371(6536):eabc4552.","journal-title":"Science"},{"issue":"3","key":"3599_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.cell.2017.07.008","volume":"170","author":"T Yu","year":"2017","unstructured":"Yu T, Guo F, Yu Y, Sun T, Ma D, Han J, et al. Fusobacterium nucleatum promotes Chemoresistance to Colorectal Cancer by modulating Autophagy. Cell. 2017;170(3):548\u2013e6316.","journal-title":"Cell"},{"issue":"10","key":"3599_CR15","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1158\/2159-8290.CD-21-0324","volume":"11","author":"RJ Knippel","year":"2021","unstructured":"Knippel RJ, Drewes JL, Sears CL. The Cancer Microbiome: recent highlights and knowledge gaps. Cancer Discov. 2021;11(10):2378\u201395.","journal-title":"Cancer Discov"},{"issue":"5","key":"3599_CR16","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B, et al. Commensal microbiota promote Lung Cancer Development via \u03b3\u03b4 T cells. Cell. 2019;176(5):998\u2013e101316.","journal-title":"Cell"},{"issue":"10","key":"3599_CR17","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1128\/AEM.00242-14","volume":"80","author":"C Urbaniak","year":"2014","unstructured":"Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, et al. Microbiota of human breast tissue. Appl Environ Microbiol. 2014;80(10):3007\u201314.","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"3599_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13568-019-0763-z","volume":"9","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang Q, Zhao J, Gong L, Zhang Y, Wang X, et al. Altered diversity and composition of the gut microbiome in patients with cervical cancer. AMB Express. 2019;9(1):40.","journal-title":"AMB Express"},{"issue":"6230","key":"3599_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1126\/science.aaa4972","volume":"348","author":"WS Garrett","year":"2015","unstructured":"Garrett WS. Cancer and the microbiota. Science. 2015;348(6230):80\u20136.","journal-title":"Science"},{"issue":"11","key":"3599_CR20","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nrc3610","volume":"13","author":"RF Schwabe","year":"2013","unstructured":"Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer. 2013;13(11):800\u201312.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3599_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1158\/1940-6207.CAPR-16-0249","volume":"10","author":"SV Rajagopala","year":"2017","unstructured":"Rajagopala SV, Vashee S, Oldfield LM, Suzuki Y, Venter JC, Telenti A, et al. The human microbiome and Cancer. Cancer Prev Res (Phila). 2017;10(4):226\u201334.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"6371","key":"3599_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.aan3706","volume":"359","author":"B Routy","year":"2018","unstructured":"Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daill\u00e8re R, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359(6371):91\u20137.","journal-title":"Science"},{"issue":"2","key":"3599_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/1471-0528.15854","volume":"127","author":"J Norenhag","year":"2020","unstructured":"Norenhag J, Du J, Olovsson M, Verstraelen H, Engstrand L, Brusselaers N. The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis. BJOG. 2020;127(2):171\u201380.","journal-title":"BJOG"},{"issue":"8","key":"3599_CR24","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/infdis\/jiz325","volume":"220","author":"H Wang","year":"2019","unstructured":"Wang H, Ma Y, Li R, Chen X, Wan L, Zhao W. Associations of Cervicovaginal Lactobacilli with High-Risk Human Papillomavirus infection, cervical intraepithelial neoplasia, and Cancer: a systematic review and Meta-analysis. J Infect Dis. 2019;220(8):1243\u201354.","journal-title":"J Infect Dis"},{"key":"3599_CR25","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"9","key":"3599_CR26","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"3599_CR27","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","journal-title":"BMJ"},{"key":"3599_CR28","unstructured":"Penson DFKS, Jules A. Evaluation and Treatment of Cryptorchidism. Comparative Effectiveness Review No. 88. Prepared by the Vanderbilt Evidence-based Practice Center under Contract. 2012."},{"issue":"1","key":"3599_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s12905-023-02829-8","volume":"23","author":"M Vali","year":"2023","unstructured":"Vali M, Maleki Z, Nikbakht HA, Hassanipour S, Kouhi A, Nazemi S, et al. Survival rate of cervical cancer in Asian countries: a systematic review and meta-analysis. BMC Womens Health. 2023;23(1):671.","journal-title":"BMC Womens Health"},{"key":"3599_CR30","unstructured":"Rohatgi A. WebPlotDigitizer. 2020, https:\/\/automeris.io\/WebPlotDigitizer."},{"issue":"1","key":"3599_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40614-021-00284-0","volume":"45","author":"O Aydin","year":"2022","unstructured":"Aydin O, Yassikaya MY. Validity and reliability analysis of the PlotDigitizer Software Program for data extraction from single-case graphs. Perspect Behav Sci. 2022;45(1):239\u201357.","journal-title":"Perspect Behav Sci"},{"issue":"2","key":"3599_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/0145445516673998","volume":"41","author":"D Drevon","year":"2017","unstructured":"Drevon D, Fursa SR, Malcolm AL. Intercoder Reliability and Validity of WebPlotDigitizer in extracting Graphed Data. Behav Modif. 2017;41(2):323\u201339.","journal-title":"Behav Modif"},{"issue":"5","key":"3599_CR33","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jrsm.1429","volume":"11","author":"J Shi","year":"2020","unstructured":"Shi J, Luo D, Weng H, Zeng XT, Lin L, Chu H, et al. Optimally estimating the sample standard deviation from the five-number summary. Res Synth Methods. 2020;11(5):641\u201354.","journal-title":"Res Synth Methods"},{"issue":"5","key":"3599_CR34","doi-asserted-by":"publisher","first-page":"e0015122","DOI":"10.1128\/spectrum.00151-22","volume":"10","author":"H Liu","year":"2022","unstructured":"Liu H, Liang H, Li D, Wang M, Li Y. Association of Cervical Dysbacteriosis, HPV Oncogene expression, and cervical lesion progression. Microbiol Spectr. 2022;10(5):e0015122.","journal-title":"Microbiol Spectr"},{"issue":"24","key":"3599_CR35","doi-asserted-by":"publisher","first-page":"5037","DOI":"10.1002\/cam4.4801","volume":"11","author":"C Li","year":"2022","unstructured":"Li C, Zhang Z, Yang Y, Liao H. Changes in the cervicovaginal microbiota composition of HPV16-infected patients after clinical treatment. Cancer Med. 2022;11(24):5037\u201349.","journal-title":"Cancer Med"},{"issue":"1","key":"3599_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1186\/s12879-020-05324-9","volume":"20","author":"Y Chen","year":"2020","unstructured":"Chen Y, Qiu X, Wang W, Li D, Wu A, Hong Z, et al. Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort. BMC Infect Dis. 2020;20(1):629.","journal-title":"BMC Infect Dis"},{"key":"3599_CR37","doi-asserted-by":"publisher","first-page":"615439","DOI":"10.3389\/fonc.2021.615439","volume":"11","author":"L Jiang","year":"2021","unstructured":"Jiang L, Li B, Zhang Y, Ma S, Liu C, Liang F, et al. Influence of pelvic intensity-modulated Radiation Therapy with Concurrent Cisplatin-based chemotherapy of Cervical Cancer on the vaginal microbiome. Front Oncol. 2021;11:615439.","journal-title":"Front Oncol"},{"issue":"12","key":"3599_CR38","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.3390\/cancers12123800","volume":"12","author":"G-U Kang","year":"2020","unstructured":"Kang G-U, Jung D-R, Lee YH, Jeon SY, Han HS, Chong GO, et al. Dynamics of Fecal Microbiota with and without Invasive Cervical Cancer and its application in early diagnosis. Cancers. 2020;12(12):3800.","journal-title":"Cancers"},{"key":"3599_CR39","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2147\/IJWH.S406596","volume":"15","author":"X Li","year":"2023","unstructured":"Li X, Wu J, Wu Y, Duan Z, Luo M, Li L, et al. Imbalance of vaginal microbiota and immunity: two main accomplices of Cervical Cancer in Chinese women. Int J Women\u2019s Health. 2023;15:987\u20131002.","journal-title":"Int J Women\u2019s Health"},{"key":"3599_CR40","doi-asserted-by":"publisher","first-page":"1005537","DOI":"10.3389\/fonc.2022.1005537","volume":"12","author":"N Zeber-Lubecka","year":"2022","unstructured":"Zeber-Lubecka N, Kulecka M, Lindner B, Krynicki R, Paziewska A, Nowakowski A, et al. Increased diversity of a cervical microbiome associates with cervical cancer. Front Oncol. 2022;12:1005537.","journal-title":"Front Oncol"},{"issue":"4","key":"3599_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.33073\/pjm-2021-046","volume":"70","author":"Q Zhai","year":"2021","unstructured":"Zhai Q, Zhang W, Zhang Z, Fu Y, Li Y, Wang X, et al. Characteristics of the Cervicovaginal Microenvironment in Childbearing-Age women with different degrees of cervical lesions and HR-HPV positivity. Pol J Microbiol. 2021;70(4):489\u2013500.","journal-title":"Pol J Microbiol"},{"issue":"1","key":"3599_CR42","doi-asserted-by":"publisher","first-page":"2186780","DOI":"10.1080\/01443615.2023.2186780","volume":"43","author":"W Zeng","year":"2023","unstructured":"Zeng W, Liang Y, Zhou J, Lin H, Huang L, He D, et al. Vaginal microecological changes of different degrees of cervical lesions in Hakka women in Meizhou City. J Obstet Gynaecol. 2023;43(1):2186780.","journal-title":"J Obstet Gynaecol"},{"issue":"1","key":"3599_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/diagnostics13010140","volume":"13","author":"MK Ivanov","year":"2023","unstructured":"Ivanov MK, Brenner EV, Hodkevich AA, Dzyubenko VV, Krasilnikov SE, Mansurova AS, et al. Cervicovaginal-Microbiome analysis by 16S sequencing and real-time PCR in patients from Novosibirsk (Russia) with cervical lesions and several years after Cancer Treatment. Diagnostics. 2023;13(1):140.","journal-title":"Diagnostics"},{"issue":"4","key":"3599_CR44","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12275-023-00039-3","volume":"61","author":"Y Ma","year":"2023","unstructured":"Ma Y, Li Y, Liu Y, Cao L, Han X, Gao S, et al. Vaginal Microbiome Dysbiosis is Associated with the different cervical Disease Status. J Microbiol. 2023;61(4):423\u201332.","journal-title":"J Microbiol"},{"issue":"15","key":"3599_CR45","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.3390\/jcm12154979","volume":"12","author":"IL Stoian","year":"2023","unstructured":"Stoian IL, Botezatu A, Fudulu A, Ilea CG, Socolov DG. Exploring microbiota diversity in cervical lesion progression and HPV infection through 16S rRNA gene metagenomic sequencing. J Clin Med. 2023;12(15):4979.","journal-title":"J Clin Med"},{"issue":"19","key":"3599_CR46","first-page":"17371","volume":"149","author":"X Zheng","year":"2023","unstructured":"Zheng X, Hu N, Liu J, Zhao K, Li H, Wang J, et al. Cervicovaginal microbiota disorder combined with the change of cytosine phosphate guanine motif- toll like receptor 9 axis was associated with cervical cancerization. J Cancer Res Clin Oncol. 2023;149(19):17371\u201381.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"4","key":"3599_CR47","doi-asserted-by":"publisher","first-page":"833","DOI":"10.3390\/microorganisms11040833","volume":"11","author":"B Teka","year":"2023","unstructured":"Teka B, Yoshida-Court K, Firdawoke E, Chanyalew Z, Gizaw M, Addissie A, et al. Cervicovaginal Microbiota profiles in Precancerous lesions and Cervical Cancer among Ethiopian Women. Microorganisms. 2023;11(4):833.","journal-title":"Microorganisms"},{"issue":"2","key":"3599_CR48","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/microorganisms9020294","volume":"9","author":"G-U Kang","year":"2021","unstructured":"Kang G-U, Jung D-R, Lee YH, Jeon SY, Han HS, Chong GO, et al. Potential Association between vaginal microbiota and cervical carcinogenesis in Korean women: a Cohort Study. Microorganisms. 2021;9(2):294.","journal-title":"Microorganisms"},{"issue":"3","key":"3599_CR49","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/cancers11030309","volume":"11","author":"M Kwon","year":"2019","unstructured":"Kwon M, Seo SS, Kim MK, Lee DO, Lim MC. Compositional and functional differences between microbiota and cervical carcinogenesis as identified by shotgun metagenomic sequencing. Cancers. 2019;11(3):309.","journal-title":"Cancers"},{"issue":"8","key":"3599_CR50","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/ijgc-2020-001547","volume":"30","author":"TT Sims","year":"2020","unstructured":"Sims TT, Biegert GWG, Ramogola-Masire D, Ngoni K, Solley T, Ning MS, et al. Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer. Int J Gynecol Cancer. 2020;30(8):1151\u20136.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"3599_CR51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ygyno.2019.09.002","volume":"155","author":"TT Sims","year":"2019","unstructured":"Sims TT, Colbert LE, Zheng J, Delgado Medrano AY, Hoffman KL, Ramondetta L, et al. Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls. Gynecol Oncol. 2019;155(2):237\u201344.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"3599_CR52","doi-asserted-by":"publisher","first-page":"e0238705","DOI":"10.1371\/journal.pone.0238705","volume":"15","author":"KA So","year":"2020","unstructured":"So KA, Yang EJ, Kim NR, Hong SR, Lee J-H, Hwang C-S, et al. Changes of vaginal microbiota during cervical carcinogenesis in women with human papillomavirus infection. PLoS ONE. 2020;15(9):e0238705.","journal-title":"PLoS ONE"},{"issue":"1","key":"3599_CR53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s00248-021-01800-0","volume":"84","author":"Z Wang","year":"2022","unstructured":"Wang Z, Xiao R, Huang J, Qin X, Hu D, Guo E, et al. The diversity of Vaginal Microbiota predicts Neoadjuvant Chemotherapy responsiveness in locally Advanced Cervical Cancer. Microb Ecol. 2022;84(1):302\u201313.","journal-title":"Microb Ecol"},{"issue":"2","key":"3599_CR54","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ygyno.2021.08.016","volume":"163","author":"S Wu","year":"2021","unstructured":"Wu S, Ding X, Kong Y, Acharya S, Wu H, Huang C, et al. The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females. Gynecol Oncol. 2021;163(2):348\u201357.","journal-title":"Gynecol Oncol"},{"key":"3599_CR55","doi-asserted-by":"publisher","first-page":"538336","DOI":"10.3389\/fcimb.2020.538336","volume":"10","author":"Y Xie","year":"2020","unstructured":"Xie Y, Feng Y, Li W, Zhan F, Huang G, Hu H, et al. Revealing the disturbed vaginal micobiota caused by Cervical Cancer using high-throughput sequencing technology. Front Cell Infect Microbiol. 2020;10:538336.","journal-title":"Front Cell Infect Microbiol"},{"issue":"10","key":"3599_CR56","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3724\/abbs.2022149","volume":"54","author":"H Xu","year":"2022","unstructured":"Xu H, Liu L, Xu F, Liu M, Song Y, Chen J, et al. Microbiome-metabolome analysis reveals cervical lesion alterations. Acta Biochim Biophys Sin. 2022;54(10):1552\u201360.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"1","key":"3599_CR57","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12866-021-02152-y","volume":"21","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Li T, Zhang D, Zong X, Bai H, Bi H, et al. Distinction between vaginal and cervical microbiota in high-risk human papilloma virus-infected women in China. BMC Microbiol. 2021;21(1):90.","journal-title":"BMC Microbiol"},{"issue":"9","key":"3599_CR58","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1136\/ijgc-2019-000801","volume":"30","author":"A Tsakmaklis","year":"2020","unstructured":"Tsakmaklis A, Vehreschild M, Farowski F, Trommer M, Kohler C, Herter J, et al. Changes in the cervical microbiota of cervical cancer patients after primary radio-chemotherapy. Int J Gynecol Cancer. 2020;30(9):1326\u201330.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"3599_CR59","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2019.12.040","volume":"107","author":"A Mitra","year":"2020","unstructured":"Mitra A, Grossman Biegert GW, Delgado AY, Karpinets TV, Solley TN, Mezzari MP, et al. Microbial Diversity and Composition is Associated with patient-reported toxicity during Chemoradiation Therapy for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020;107(1):163\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"3599_CR60","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1111\/jcmm.14289","volume":"23","author":"Z Wang","year":"2019","unstructured":"Wang Z, Wang Q, Wang X, Zhu L, Chen J, Zhang B, et al. Gut microbial dysbiosis is associated with development and progression of radiation enteritis during pelvic radiotherapy. J Cell Mol Med. 2019;23(5):3747\u201356.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"3599_CR61","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.ccell.2023.09.012","volume":"41","author":"LE Colbert","year":"2023","unstructured":"Colbert LE, El Alam MB, Wang R, Karpinets T, Lo D, Lynn EJ, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41(11):1945\u2013e6211.","journal-title":"Cancer Cell"},{"issue":"1","key":"3599_CR62","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12885-022-09452-0","volume":"22","author":"H Wang","year":"2022","unstructured":"Wang H, Jiang Y, Liang Y, Wei L, Zhang W, Li L. Observation of the cervical microbiome in the progression of cervical intraepithelial neoplasia. BMC Cancer. 2022;22(1):362.","journal-title":"BMC Cancer"},{"issue":"1","key":"3599_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/jrms.JRMS_757_19","volume":"26","author":"GL Manzanares-Leal","year":"2021","unstructured":"Manzanares-Leal GL, Coronel-Mart\u00ednez J, Rodr\u00edguez-Morales M, Bustamante-Montes LP, Sandoval-Trujillo H, Ram\u00edrez-Dur\u00e1n N. Changes in the diversity of local cervical bacteria in women with cervical cancer receiving antineoplastic treatment. J Res Med Sci. 2021;26(1):56.","journal-title":"J Res Med Sci"},{"issue":"48","key":"3599_CR64","doi-asserted-by":"publisher","first-page":"24285","DOI":"10.1073\/pnas.1912129116","volume":"116","author":"I Sobhani","year":"2019","unstructured":"Sobhani I, Bergsten E, Couffin S, Amiot A, Nebbad B, Barau C, et al. Colorectal cancer-associated microbiota contributes to oncogenic epigenetic signatures. Proc Natl Acad Sci U S A. 2019;116(48):24285\u201395.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3599_CR65","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.3389\/fimmu.2020.02184","volume":"11","author":"E Amabebe","year":"2020","unstructured":"Amabebe E, Anumba DOC. Female gut and genital Tract Microbiota-Induced Crosstalk and Differential effects of short-chain fatty acids on Immune Sequelae. Front Immunol. 2020;11:2184.","journal-title":"Front Immunol"},{"issue":"3","key":"3599_CR66","first-page":"331","volume":"89","author":"KL Nunn","year":"2016","unstructured":"Nunn KL, Forney LJ. Unraveling the dynamics of the human vaginal microbiome. Yale J Biol Med. 2016;89(3):331\u20137.","journal-title":"Yale J Biol Med"},{"issue":"4","key":"3599_CR67","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.chom.2011.10.003","volume":"10","author":"CS Plottel","year":"2011","unstructured":"Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011;10(4):324\u201335.","journal-title":"Cell Host Microbe"},{"key":"3599_CR68","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/1479-5876-10-253","volume":"10","author":"R Flores","year":"2012","unstructured":"Flores R, Shi J, Fuhrman B, Xu X, Veenstra TD, Gail MH, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med. 2012;10:253.","journal-title":"J Transl Med"},{"key":"3599_CR69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","volume":"103","author":"JM Baker","year":"2017","unstructured":"Baker JM, Al-Nakkash L, Herbst-Kralovetz MM. Estrogen-gut microbiome axis: physiological and clinical implications. Maturitas. 2017;103:45\u201353.","journal-title":"Maturitas"},{"issue":"5","key":"3599_CR70","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1097\/MS9.0000000000001740","volume":"86","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Samethadka Nayak S, Maddineni G, Mahapatro A, Keivanlou MH, Soltani Moghadam S, et al. Can modulation of gut microbiota affect anthropometric indices in patients with non-alcoholic fatty liver disease? An umbrella meta-analysis of randomized controlled trials. Ann Med Surg (Lond). 2024;86(5):2900\u201310.","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"3599_CR71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13643-023-02299-x","volume":"12","author":"A Naghipour","year":"2023","unstructured":"Naghipour A, Amini-Salehi E, Orang Gorabzarmakhi M, Shahdkar M, Fouladi B, Alipourfard I, et al. Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study. Syst Rev. 2023;12(1):144.","journal-title":"Syst Rev"},{"issue":"6","key":"3599_CR72","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/nutrit\/nuad086","volume":"82","author":"E Amini-Salehi","year":"2024","unstructured":"Amini-Salehi E, Hassanipour S, Keivanlou MH, Shahdkar M, Orang Goorabzarmakhi M, Vakilpour A, et al. The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis. Nutr Rev. 2024;82(6):815\u201330.","journal-title":"Nutr Rev"},{"key":"3599_CR73","doi-asserted-by":"crossref","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R. Gut-microbiota-derived metabolites maintain gut and systemic Immune Homeostasis. Cells. 2023;12(5).","DOI":"10.3390\/cells12050793"},{"issue":"1","key":"3599_CR74","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","volume":"8","author":"LY Zhao","year":"2023","unstructured":"Zhao LY, Mei JX, Yu G, Lei L, Zhang WH, Liu K, et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications. Signal Transduct Target Ther. 2023;8(1):201.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"3599_CR75","first-page":"e47072","volume":"15","author":"AS Algrafi","year":"2023","unstructured":"Algrafi AS, Jamal AA, Ismaeel DM. Microbiota as a New Target in Cancer Pathogenesis and Treatment. Cureus. 2023;15(10):e47072.","journal-title":"Cureus"},{"issue":"1","key":"3599_CR76","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1136\/gutjnl-2017-313789","volume":"67","author":"S Gerassy-Vainberg","year":"2018","unstructured":"Gerassy-Vainberg S, Blatt A, Danin-Poleg Y, Gershovich K, Sabo E, Nevelsky A, et al. Radiation induces proinflammatory dysbiosis: transmission of inflammatory susceptibility by host cytokine induction. Gut. 2018;67(1):97\u2013107.","journal-title":"Gut"},{"issue":"4","key":"3599_CR77","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00280-018-3549-0","volume":"81","author":"C Panebianco","year":"2018","unstructured":"Panebianco C, Adamberg K, Jaagura M, Copetti M, Fontana A, Adamberg S, et al. Influence of gemcitabine chemotherapy on the microbiota of pancreatic cancer xenografted mice. Cancer Chemother Pharmacol. 2018;81(4):773\u201382.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3599_CR78","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40425-018-0332-z","volume":"6","author":"FZ Acero Brand","year":"2018","unstructured":"Acero Brand FZ, Suter N, Adam JP, Faulques B, Maietta A, Souli\u00e8res D, et al. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab. J Immunother Cancer. 2018;6(1):22.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"3599_CR79","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ygyno.2015.04.036","volume":"138","author":"D Chase","year":"2015","unstructured":"Chase D, Goulder A, Zenhausern F, Monk B, Herbst-Kralovetz M. The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. Gynecol Oncol. 2015;138(1):190\u2013200.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"3599_CR80","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/apt.13302","volume":"42","author":"E Montassier","year":"2015","unstructured":"Montassier E, Gastinne T, Vangay P, Al-Ghalith GA, Bruley des Varannes S, Massart S, et al. Chemotherapy-driven dysbiosis in the intestinal microbiome. Aliment Pharmacol Ther. 2015;42(5):515\u201328.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3599_CR81","doi-asserted-by":"publisher","first-page":"e83644","DOI":"10.1371\/journal.pone.0083644","volume":"9","author":"XB Lin","year":"2014","unstructured":"Lin XB, Farhangfar A, Valcheva R, Sawyer MB, Dieleman L, Schieber A, et al. The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats. PLoS ONE. 2014;9(1):e83644.","journal-title":"PLoS ONE"},{"issue":"6005","key":"3599_CR82","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1126\/science.1191175","volume":"330","author":"BD Wallace","year":"2010","unstructured":"Wallace BD, Wang H, Lane KT, Scott JE, Orans J, Koo JS, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science. 2010;330(6005):831\u20135.","journal-title":"Science"},{"issue":"7","key":"3599_CR83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.trecan.2021.01.010","volume":"7","author":"CB Zhou","year":"2021","unstructured":"Zhou CB, Zhou YL, Fang JY. Gut microbiota in Cancer Immune Response and Immunotherapy. Trends Cancer. 2021;7(7):647\u201360.","journal-title":"Trends Cancer"},{"issue":"6","key":"3599_CR84","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","volume":"29","author":"JH Maduro","year":"2003","unstructured":"Maduro JH, Pras E, Willemse PH, de Vries EG. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev. 2003;29(6):471\u201388.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"3599_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40425-019-0574-4","volume":"7","author":"J Fessler","year":"2019","unstructured":"Fessler J, Matson V, Gajewski TF. Exploring the emerging role of the microbiome in cancer immunotherapy. J Immunother Cancer. 2019;7(1):108.","journal-title":"J Immunother Cancer"},{"issue":"Suppl 1","key":"3599_CR86","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1093\/infdis\/jiw184","volume":"214","author":"DH Martin","year":"2016","unstructured":"Martin DH, Marrazzo JM. The vaginal microbiome: current understanding and future directions. J Infect Dis. 2016;214(Suppl 1):S36\u201341.","journal-title":"J Infect Dis"},{"issue":"4","key":"3599_CR87","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.trsl.2012.02.008","volume":"160","author":"RJ Hickey","year":"2012","unstructured":"Hickey RJ, Zhou X, Pierson JD, Ravel J, Forney LJ. Understanding vaginal microbiome complexity from an ecological perspective. Transl Res. 2012;160(4):267\u201382.","journal-title":"Transl Res"},{"issue":"1","key":"3599_CR88","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1038\/s41467-020-15856-y","volume":"11","author":"A Mitra","year":"2020","unstructured":"Mitra A, MacIntyre DA, Ntritsos G, Smith A, Tsilidis KK, Marchesi JR, et al. The vaginal microbiota associates with the regression of untreated cervical intraepithelial neoplasia 2 lesions. Nat Commun. 2020;11(1):1999.","journal-title":"Nat Commun"},{"issue":"9","key":"3599_CR89","doi-asserted-by":"publisher","first-page":"e1005889","DOI":"10.1371\/journal.ppat.1005889","volume":"12","author":"AS Zevin","year":"2016","unstructured":"Zevin AS, Xie IY, Birse K, Arnold K, Romas L, Westmacott G, et al. Microbiome composition and function drives Wound-Healing impairment in the female genital tract. PLoS Pathog. 2016;12(9):e1005889.","journal-title":"PLoS Pathog"},{"issue":"3","key":"3599_CR90","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s12253-015-9913-z","volume":"21","author":"JV Fernandes","year":"2015","unstructured":"Fernandes JV, Cobucci RN, Jatob\u00e1 CA, Fernandes TA, de Azevedo JW, de Ara\u00fajo JM. The role of the mediators of inflammation in cancer development. Pathol Oncol Res. 2015;21(3):527\u201334.","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"3599_CR91","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/v5020708","volume":"5","author":"F De Marco","year":"2013","unstructured":"De Marco F. Oxidative stress and HPV carcinogenesis. Viruses. 2013;5(2):708\u201331.","journal-title":"Viruses"},{"issue":"5","key":"3599_CR92","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1042\/CS20050369","volume":"110","author":"J Doorbar","year":"2006","unstructured":"Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond). 2006;110(5):525\u201341.","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"3599_CR93","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"issue":"6","key":"3599_CR94","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nrc3728","volume":"14","author":"RD Steenbergen","year":"2014","unstructured":"Steenbergen RD, Snijders PJ, Heideman DA, Meijer CJ. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14(6):395\u2013405.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3599_CR95","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12967-024-05124-8","volume":"22","author":"W Zhang","year":"2024","unstructured":"Zhang W, Yin Y, Jiang Y, Yang Y, Wang W, Wang X, et al. Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer. J Transl Med. 2024;22(1):396.","journal-title":"J Transl Med"},{"issue":"2","key":"3599_CR96","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1128\/CMR.00075-15","volume":"29","author":"AB Onderdonk","year":"2016","unstructured":"Onderdonk AB, Delaney ML, Fichorova RN. The human microbiome during bacterial vaginosis. Clin Microbiol Rev. 2016;29(2):223\u201338.","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"3599_CR97","doi-asserted-by":"publisher","first-page":"e30633","DOI":"10.1371\/journal.pone.0030633","volume":"7","author":"K Fethers","year":"2012","unstructured":"Fethers K, Twin J, Fairley CK, Fowkes FJ, Garland SM, Fehler G, et al. Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS ONE. 2012;7(2):e30633.","journal-title":"PLoS ONE"},{"issue":"1","key":"3599_CR98","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13073-021-00977-w","volume":"13","author":"A Mitra","year":"2021","unstructured":"Mitra A, MacIntyre DA, Paraskevaidi M, Moscicki AB, Mahajan V, Smith A, et al. The vaginal microbiota and innate immunity after local excisional treatment for cervical intraepithelial neoplasia. Genome Med. 2021;13(1):176.","journal-title":"Genome Med"},{"issue":"12","key":"3599_CR99","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/OLQ.0b013e3181e50026","volume":"37","author":"A Hemmerling","year":"2010","unstructured":"Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, et al. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis. 2010;37(12):745\u201350.","journal-title":"Sex Transm Dis"},{"issue":"11","key":"3599_CR100","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/OLQ.0b013e3182267ac4","volume":"38","author":"BM Ngugi","year":"2011","unstructured":"Ngugi BM, Hemmerling A, Bukusi EA, Kikuvi G, Gikunju J, Shiboski S, et al. Effects of bacterial vaginosis-associated bacteria and sexual intercourse on vaginal colonization with the probiotic Lactobacillus crispatus CTV-05. Sex Transm Dis. 2011;38(11):1020\u20137.","journal-title":"Sex Transm Dis"},{"issue":"6","key":"3599_CR101","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","volume":"14","author":"JL Alexander","year":"2017","unstructured":"Alexander JL, Wilson ID, Teare J, Marchesi JR, Nicholson JK, Kinross JM. Gut microbiota modulation of chemotherapy efficacy and toxicity. Nat Rev Gastroenterol Hepatol. 2017;14(6):356\u201365.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3599_CR102","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.maturitas.2018.03.012","volume":"112","author":"EM Wilkinson","year":"2018","unstructured":"Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. Microbiota-drug interactions: impact on metabolism and efficacy of therapeutics. Maturitas. 2018;112:53\u201363.","journal-title":"Maturitas"},{"issue":"1","key":"3599_CR103","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00280-010-1310-4","volume":"67","author":"A Kurita","year":"2011","unstructured":"Kurita A, Kado S, Matsumoto T, Asakawa N, Kaneda N, Kato I, et al. Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of \u03b2-glucuronidase activity in intestinal lumen. Cancer Chemother Pharmacol. 2011;67(1):201\u201313.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6371","key":"3599_CR104","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359(6371):104\u20138.","journal-title":"Science"},{"issue":"6371","key":"3599_CR105","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359(6371):97\u2013103.","journal-title":"Science"},{"key":"3599_CR106","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3199993","author":"LE Colbert","year":"2018","unstructured":"Colbert LE, et al. The gut and cervical microbiome promote immune activation and response to chemoradiation in cervical cancer. Cancer Cell. 2018. https:\/\/doi.org\/10.2139\/ssrn.3199993.","journal-title":"Cancer Cell"},{"key":"3599_CR107","doi-asserted-by":"crossref","unstructured":"Clarridge JE 3. Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev. 2004;17(4):840\u201362. table of contents.","DOI":"10.1128\/CMR.17.4.840-862.2004"},{"issue":"10","key":"3599_CR108","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1469-0691.2008.02070.x","volume":"14","author":"PC Woo","year":"2008","unstructured":"Woo PC, Lau SK, Teng JL, Tse H, Yuen KY. Then and now: use of 16S rDNA gene sequencing for bacterial identification and discovery of novel bacteria in clinical microbiology laboratories. Clin Microbiol Infect. 2008;14(10):908\u201334.","journal-title":"Clin Microbiol Infect"},{"key":"3599_CR109","doi-asserted-by":"crossref","unstructured":"Wensel CR, Pluznick JL, Salzberg SL, Sears CL. Next-generation sequencing: insights to advance clinical investigations of the microbiome. J Clin Invest. 2022;132(7).","DOI":"10.1172\/JCI154944"},{"issue":"2","key":"3599_CR110","doi-asserted-by":"publisher","first-page":"e0009022","DOI":"10.1128\/spectrum.00090-22","volume":"10","author":"CS Poulsen","year":"2022","unstructured":"Poulsen CS, Ekstr\u00f8m CT, Aarestrup FM, Pamp SJ. Library Preparation and sequencing platform introduce Bias in Metagenomic-based characterizations of Microbiomes. Microbiol Spectr. 2022;10(2):e0009022.","journal-title":"Microbiol Spectr"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03599-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-025-03599-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-025-03599-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T04:31:29Z","timestamp":1739593889000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-025-03599-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3599"],"URL":"https:\/\/doi.org\/10.1186\/s12905-025-03599-1","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}